Nov 10 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2023 Sep 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 313 mln 309 mln 400 mln
(+1.6 pct) (-2.1 pct) (-10.7 pct)
Operating loss 457 mln loss 251 mln loss 1.40
Recurring loss 453 mln loss 239 mln loss 1.41
Net loss 443 mln loss 226 mln loss 1.39
EPS loss 14.02 yen loss 7.70 yen loss 44.60 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T